Despite significant advancements in reproductive endocrinology and infertility over the past decade, systemic inequities ...

A recent study published in Clinical Interventions in Aging found that among 479 patients aged 80 and older undergoing femur ...

A recent study published in the journal Scientific Reports correlates higher levels of pollutant particulate matter to higher ...

Short-term menopausal hormone therapy (MHT) did not have long-term cognitive effects when given to women in early ...

"SEC outperformed placebo by effectively reducing pruritus intensity, restoring clinical normalcy to skin lesions, and ...

Recent research has established that the scores for noninvasive liver fibrosis such as the Fibrosis-4 (FIB-4) score, the ...

More time spent sitting, reclining or lying down during the day may increase the risk of cardiovascular disease (CVD) and ...

Karnataka: Shilpa Medicare's Joint Venture Oncosol (50:50 JV with Liqmeds Lifecare Limited, a Zydus group company and Koana ...

New Delhi: Intas Pharma has got the go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug ...

The Union Health Ministry, in a response to an RTI dated November 7, disclosed that the proposed amendments to the Drugs and ...

In relation to the successful completion of Phase I clinical trials, Shilpa Medicare Ltd has announced that the Subject ...

Anakapalli: In a devastating incident at a private pharma company located in Parawada Pharma City, one worker died, and two ...